I do not believe that additional approval would be required for a medical device that has already had a PMA. However, all medical device manufacturers are subject to audit from the FDA. Audits can be conducted at certain intervals depending on the type of product or company. They will look at the quality systems put in place to make sure all the requirements are met. A medical device manufacturer will also want to keep up with certifications like ISO 13485

After doing some additional research tied with this question, I believe that I can provide some additional information from jal58's response. The FDA does not issue renewable licenses for medical devices. Instead, each manufacturer just has to ensure ongoing compliance. Once a device is approved by the FDA, additional FDA approval is only required if significant changes are made to the device or the manufacturing process for the device. However, like jal58 mentioned, auditing is a common practice from the FDA so companies have to maintain a compliant quality management system. Manufacturers themselves are on the hook when problems arise so they should be able to handle complaints and implement corrective actions when a problem does occur. Basically, companies just need to maintain their internal systems after the FDA approves their product and manufacturing process. 

I like how both responses point out that it’s less about “renewing a license” and more about continuous compliance. Another thing I’d add, from my own experience in industry, is that project management and regulatory teams often spend a lot of time on documentation; updating technical files, tracking design changes, and making sure everything is traceable in case of an inspection. It’s not necessarily complicated in concept, but it can be very detail-heavy, especially when even small changes might trigger regulatory review or additional validation. So it seems like the real challenge isn’t one big approval process, but the constant coordination between engineering, quality, and regulatory teams to make sure nothing slips through the cracks.

I like how it is very clear that continuous compliance is the main point regarding FDA “licensure.” From the standpoint of project management, this moves the focus from one approval milestone to continuous coordination across the company. Regulatory and project management teams are usually the ones that are responsible for quality system management, documentation, and reviewing changes to the product or manufacturing process. Small modifications can trigger the need for more validation or review. 

The level of detail and consistency required for these processes makes it challenging. Companies should be prepared for FDA audits at any time and this means that they should have traceability between all records, inputs, and outputs. With issues, manufacturers are responsible for handling complaints, finding the root cause, and implementing corrective and preventative actions. This demonstrates how close project management and regulatory work are connected in the medical device industry, a point also mentioned by Sami above. Project managers play a key role in making sure timelines and costs work with regulatory requirements. I’m interested to see how different companies structure their regulatory work in regards to licensing. Is the responsibility distributed across individual product teams and project managers, or are there designated teams to ensure licensing is maintained for every product? What structure do you think is the most effective? How can AI be incorporated in licensing practices for different companies to ensure they stay compliant and maintain their licenses without “losing the plot” and becoming detrimental to the company?